Michael Halstead
CEO, Cybin D/B/A Helus Pharma
Companies#
| Company | Role | World rank | Market cap | Since Jan 2024 |
|---|---|---|---|---|
| Cybin D/B/A Helus Pharma🇨🇦 | CEO | #10,807 | $743 M | — |
Michael Halstead's share trades#
Shares Michael Halstead reported buying, selling or receiving on SEC Form 4 as an insider: $1.3 M bought and $0 sold on the open market in all.
| Traded | Company | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | 🇨🇦 Cybin D/B/A Helus PharmaHELP | Buy | +100,000 | 13.47 | 1.3 Mlocal | 168,568 | Form 4 |